CPVT-associated CaM mutations have been shown to evoke arrhythmogenic Ca2+ waves in cardiomyocytes (Gomez-Hurtado et al., 2016; Hwang et al., 2014). The gene discussed is CALM3; the disease is catecholaminergic polymorphic ventricular tachycardia.